N023871 N0 Ruling Active

The tariff classification of Zolmitriptan (CAS-139264-17-8) imported in dosage/tablet form, from India

Issued March 19, 2008 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 3004.90.9128

Headings: 3004

Product description

The subject product, Zolmitriptan is a medicinal preparation containing Zolmitriptan, a serotonin receptor agonist, as the active ingredient. It is indicated for the acute treatment of migraine attacks with or without aura and cluster headaches.

CBP rationale

The applicable subheading for the Zolmitriptan in dosage/tablet form will be 3004.90.9128, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Other.

Full text

N023871 March 19, 2008 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9128 Mr. Colm Moynihan NorthStar Healthcare Limited 3300 Cork Airport Business Park Kinsale Road Cork, Ireland RE: The tariff classification of Zolmitriptan (CAS-139264-17-8) imported in dosage/tablet form, from India Dear Mr. Moynihan: In your letter dated February 26, 2008, you requested a tariff classification ruling. The subject product, Zolmitriptan is a medicinal preparation containing Zolmitriptan, a serotonin receptor agonist, as the active ingredient. It is indicated for the acute treatment of migraine attacks with or without aura and cluster headaches. The applicable subheading for the Zolmitriptan in dosage/tablet form will be 3004.90.9128, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Other." The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This product may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →